First Time Loading...

Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.5 AUD Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

ARX Price Targets Summary
Aroa Biosurgery Ltd

Wall Street analysts forecast ARX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARX is 1.05 AUD with a low forecast of 0.94 AUD and a high forecast of 1.26 AUD.

ARX Lowest Forecast
Wall Street Target
0.94 AUD
88% Upside
ARX Average Forecast
Wall Street Target
1.05 AUD
109% Upside
ARX Highest Forecast
Wall Street Target
1.26 AUD
152% Upside
Lowest
Price Target
0.94 AUD
88% Upside
Average
Price Target
1.05 AUD
109% Upside
Highest
Price Target
1.26 AUD
152% Upside
Aroa Biosurgery Ltd Competitors:
Price Targets
BIIB
Biogen Inc
42% Upside
H
145020
Hugel Inc
7% Upside
SPRO
Spero Therapeutics Inc
395% Upside
IGMS
IGM Biosciences Inc
128% Upside
BIIB
Biogen Inc
42% Upside
H
145020
Hugel Inc
7% Upside
SPRO
Spero Therapeutics Inc
395% Upside
IGMS
IGM Biosciences Inc
128% Upside
GLPG
Galapagos NV
59% Upside
TWST
Twist Bioscience Corp
28% Upside
MDXG
MiMedx Group Inc
74% Upside
VRTX
Vertex Pharmaceuticals Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Aroa Biosurgery Ltd

For the last 4 years the compound annual growth rate for Aroa Biosurgery Ltd's revenue is 28%. The projected CAGR for the next 3 years is 21%.

28%
Past Growth
21%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Aroa Biosurgery Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Aroa Biosurgery Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
15%
Average Beat
What are analyst estimates?

See Also

Summary
ARX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARX stock valuation using valuation multiples.
Wall Street Estimates
ARX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARX's stock price target?
Price Target
1.05 AUD

According to Wall Street analysts, the average 1-year price target for ARX is 1.05 AUD with a low forecast of 0.94 AUD and a high forecast of 1.26 AUD.

What is Aroa Biosurgery Ltd's Revenue forecast?
Projected CAGR
21%

For the last 4 years the compound annual growth rate for Aroa Biosurgery Ltd's revenue is 28%. The projected CAGR for the next 3 years is 21%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.